This COVID-19 edition of Cardio Round-up features some research on various cardiology-related topics being encountered during the pandemic.
A new study out of Wuhan, China, looks at a cohort of 645 patients with cardiac injury who had laboratory-confirmed COVID-19. “Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality,” the researchers concluded.
“Based on currently observed disease patterns, cardiovascular specialists will be actively engaged in the care of patients with COVID-19,” the authors wrote. “The infection may directly impact cardiovascular disease. Preexisting cardiovascular disease may predispose to COVID-19 infection. Those with CVD who are infected by the virus have an elevated risk of adverse outcomes, and infection, itself, is associated with cardiovascular complications.”
Implantation Depth in TAVR Procedures Influences Outcomes Reporting: Study
Researchers for this study looked at various methods of determining implant depth for transcatheter aortic valves. “The OID was reached in <30% of TAVR procedures,” the authors concluded. “The various methods applied for implant depth calculation significantly influence the outcome reporting and do not allow a uniform perception of the implant depth.”
In Case You Missed It
In this study, the authors observed changes in normal STEMI care time. Time from symptom-to-first-medical-contact was 318 minutes during the study time period compared with 82 minutes during office hours for the previous year, and 91.5 minutes during the non-office hours. “We found large delays in the small number of patients with STEMI seeking medical help after institution of these [COVID-19] infection control measures,” the authors wrote in their letter. “It is understandable that people are reluctant to go to a hospital during the COVID-19 outbreak, which explains the potential delays in seeking care.”